Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Immunological aspects of additional revaccination of adolescents against whooping cough, diphtheria and tetanus
https://doi.org/10.21508/1027-4065-2023-68-4-77-XX
Abstract
The epidemiological situation of whooping cough in many countries of the world shows an increase in the incidence, despite the high coverage of routine immunization of the child population, which indicates the need for additional booster doses in older age groups.
Purpose. The study aims at a comparative analysis of the intensity of specific immunity against whooping cough, diphtheria and tetanus in adolescent children after revaccination with different types of vaccines.
Material and methods. 121 adolescents received various preparations containing pertussis, diphtheria and tetanus as revaccination.
Results. The use of the pertussis component in preparations for revaccination of adolescents, despite the fact that they initially have a certain level of seroprotection, is not accompanied by a significant increase in specific antibody titers. Some differences related to the types of drugs used: the AbDTP-M vaccine against AbDTP had the best seroprotection after 1 month, while at the same time, as after 12 months, this ratio reversed.
Conclusion. The situation with the effectiveness of revaccination against tetanus and diphtheria with all the drugs used had a more predictable effect, which was reflected in a significant increase in the titer of specific antibodies after 1 month.
About the Authors
E. V. Prutskova
Ulyanovsk State University
Russian Federation
Russian Federation
Ulyanovsk
A. P. Cherdantsev
Ulyanovsk State University
Russian Federation
Russian Federation
Ulyanovsk
M. P. Kostinov
Mechnikov Research Institute of Vaccines and Sera; Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Moscow
References
1. Riolo M.A., Rohani P. Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proc Natl Acad Sci USA 2015; 112(5): E472–477. DOI: 10.1073/pnas.1415573112
2. Jackson D., Rohani P. The increasing application of multiplex nuclei detection tests to the diagnosis of syndromic infections. Epidemiol Infect 2013; 142(1): 1–11. DOI: 10.1017/S0950268813002367
3. Kostinov A.M., Kostinov M.P. Pertussis incidence and the effect of revaccination of preschool and school children. Infektsiya i immunitet 2018; 8(3): 284–294. (in Russ.) DOI: 10.15789/2220–7619–2018–3–284–294
4. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2020: State report. M.: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2021; 256. (in Russ.)
5. Tartof S.Y., Lewis M., Kenyon C., White K., Osborn A., Liko J. et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131(4): e1047–1052. DOI: 10.1542/peds.2012–1928
6. NCHS Bridged Race Intercensal Population Estimate for 2019. https://www.cdc.gov/pertussis/downloads/pertuss-surv-report-2019–508.pdf The link is active on 21. 05. 2023.
7. World Health Organization. Tetanus vaccines: WHO Position Paper — February 2017. Wkly Epidemiol Rec 2017; 92(6): 53–76. http://apps.who.int/iris/bitstream/10665/254582/1/WER9206.pdf?ua=1 The link is active on 21. 05. 2023.
8. World Health Organization Pertussis vaccines: WHO position paper – August 2015. Weekly Epidemiological Record 2015; 35(90): 433–460. Available at: https://www.who.int/publications/i/item/WHO-WER9035/ The link is active on 21. 05. 2023.
9. Koepke R., Eickhoff J.C., Ayele R.A., Petit A.B., Schauer S.L., Hopfensperger D.J. et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis 2014; 210(6): 942–953. DOI: 10.1093/infdis/jiu322
10. Carollo M., Pandolfi E., Tozzi A.E., Buisman A.M., Mascart F., Ausiello C.M. Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming. Vaccine 2014; 32(18): 2093–2099. DOI: 10.1016/j.vaccine.2014.02.005
11. Palazzo R., Carollo M., Bianco M., Fedele G., Schiavoni I., Pandolfi E., Villani A. et al. Persistence of T-cell immune response induced by two acellular pertussis vaccines in children five years after primary vaccination. New Microbiol 2016; 39(1): 35–47.
Review
For citations:
Prutskova E.V., Cherdantsev A.P., Kostinov M.P. Immunological aspects of additional revaccination of adolescents against whooping cough, diphtheria and tetanus. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2023;68(4):77-81. (In Russ.) https://doi.org/10.21508/1027-4065-2023-68-4-77-XX
Views:
496
Email this article 